Evidence map›Paper›PMID 40779330›Full record

ArticleStatistics in medicine2025

Addressing Population Heterogeneity for HIV Incidence Estimation Based on Recency Test.

Qi Wang, Ann Duerr, Fei Gao

Abstract read
In one paragraph

Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qi WangDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0001-9342-4053
Ann DuerrVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Fei GaoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.ORCID https://orcid.org/0000-0001-6797-5468

Funding

STATISTICAL ISSUES IN AIDS RESEARCHR37AI029168 · NIAID · UNIVERSITY OF WASHINGTON · PI JAMES P HUGHES · 1999 to 2026
$9.8M
HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSMR01DA032106 · NIDA · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DUERR, ANN C · 2011 to 2015
$6.6M
Statistical Methods for Advancing HIV PreventionR01AI177078 · NIAID · FRED HUTCHINSON CANCER CENTER · PI Fei Gao · 2023 to 2026
$1.7M
Gilead ISR-US-20-10990NIAID NIH HHS R01 AI177078NIAID NIH HHS R37 AI029168NIDA NIH HHS R01 DA032106NIH HHS R01AI177078NIH HHS R01DA032106NIH HHS R37AI029168
6 · The paper itself

Abstract

Cross-sectional HIV incidence estimation leverages recency test results to determine the HIV incidence of a population of interest, where recency test uses biomarker profiles to infer whether an HIV-positive individual was "recently" infected. This approach possesses an obvious advantage over the conventional cohort follow-up method since it avoids longitudinal follow-up and repeated HIV testing. In this manuscript, we consider the extension of cross-sectional incidence estimation to estimate the incidence of a different target population, addressing potential population heterogeneity. We propose a general framework that incorporates two scenarios: one when the target population is a subset of the population with cross-sectional recency testing data and the other with an external target population. In addition, we propose estimators to incorporate HIV subtypes, a special type of covariate that modifies the properties of recency tests, into our framework. Through simulation studies and a data application, we demonstrate the performance of the proposed methods. We conclude with a discussion on sensitivity analysis and future work to improve our framework.

Indexed as

HIV InfectionsComputer SimulationCross-Sectional StudiesHumansIncidenceModels, StatisticalHIVHIV incidenceHIV subtypespopulation heterogeneityrecency test

Identifiers

PMID40779330
PMCPMC12829530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.